P3 Health Partners Inc. is a value-based primary care organization focused on the Medicare Advantage population, which came to market through a merger with FORE Acquisition Corp (Nasdaq: FORE), a blank-check company that completed its initial public offering in 2021. The sponsor behind FORE Acquisition Corp was Fore Group, a healthcare-oriented investment vehicle. The de-SPAC transaction closed in late 2021, taking P3 public under its mission to deliver capitated, physician-led care to seniors across multiple states. The company operates in the healthcare sector, specifically within value-based care and managed Medicare services. The August 2026 Form 8-K filing, carrying accession number 0001832511-26-000032, reflects continued public-company reporting obligations for the combined entity. For complete filing history, shareholder structure, and real-time event tracking on P3 Health Partners and hundreds of other de-SPAC companies, sign up for full data access at SpacDesk.